Latest News

Pulmonary fibrosis is a condition that causes scarring of the lungs. It is often accompanied by shortness of breath, cough, rapid loss of lung function, and respiratory failure.

Wonnie Ryu, MD, MPH, is the recipient of the American Thoracic Society (ATS) Assembly on Respiratory Cell and Molecular Biology Rising Star Award.

Twelve Yale School of Medicine faculty members are among the leading experts in science, technology, engineering, mathematics, and medicine newly elected to the Connecticut Academy of Science and Engineering.

Fibrotic hypersensitivity pneumonitis is a chronic and progressive interstitial lung disease, caused by an immune response to inhaled foreign antigens or allergens. Researchers from Yale’s Section of Pulmonary, Critical Care and Sleep Medicine have used single-cell sequencing technology to provide the first high-resolution atlas of this disease, revealing a previously unrecognized immune signature. Their findings were recently published in the American Journal of Respiratory and Critical Care Medicine.

In a Q&A, Changwan "Wonnie" Ryu, MD, MPH, who recently won the ASCI Council Young Physician-Scientist Award, discusses the role of innate immunity in the development of idiopathic pulmonary fibrosis, his goal as a physician-scientist, and the inspiration behind his work.

Herzog's laboratory has had a sustained impact on the field of pulmonary fibrosis and is credited with providing new insight into convergent and divergent mechanisms existing at the interface of lung injury and repair. She also is a dedicated clinician.